Immuron (IMRN) Cash & Equivalents Growth (1y) (2017 - 2025)
Immuron (IMRN) Cash & Equivalents Growth (1y) (2017 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
988.88% |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
-68.22% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
0.00% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
4.77% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
3.35% |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
269.98% |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
17.50% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Immuron |
1.05 Bn |
1.05 Bn |
- |
-99.76% |
| Date | Value |
|---|
| Sep 2, 2025 |
-99.76% |
| Jun 30, 2025 |
-76.40% |
| Dec 31, 2024 |
-54.71% |
| Sep 9, 2024 |
-32.07% |
| Jun 30, 2024 |
-33.01% |
| Dec 31, 2023 |
-32.12% |
| Aug 30, 2023 |
11.60% |
| Jun 30, 2023 |
-27.58% |
| Dec 31, 2022 |
591.63% |
| Jun 30, 2022 |
-17.89% |
| Dec 31, 2021 |
-36.42% |
| Jun 30, 2021 |
805.35% |
| Dec 31, 2020 |
11,413.12% |
| Jun 30, 2020 |
-40.60% |
| Dec 31, 2019 |
-99.31% |
| Jun 30, 2019 |
0.21% |
| Dec 31, 2018 |
51.84% |
| Sep 27, 2018 |
9.81% |
| Aug 30, 2018 |
18.34% |
| Jun 30, 2018 |
19.25% |
